Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung

7680690830014 CH-69083 Pulver
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
6
Selling units
6
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/10/2024
Summary of Product Characteristics
Français
25/10/2024
Summary of Product Characteristics
Italien
25/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3530.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
6.9 MG Substance HBESI

Authorization holder

Norgine AG

6005 Luzern

Authorization information

Swissmedic authorization number
69083
Drug name
Agilus, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
M03CA01
Authorization status
Z
Dispensing category
B
First authorization
27/06/2024
Authorization expiration date
26/06/2029
IT Number
01.12.0.
Domain
Human medicine
Field of application
Maligne Hyperthermie

Package details

Description (FR)
AGILUS subst sèche 120 mg flac 6 pce
Description (DE)
AGILUS Trockensub 120 mg Durchstf 6 Stk
Market launch
27/06/2024
Narcotic (BTM)
No